J. Morote et al., Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen, EUR UROL, 37(5), 2000, pp. 537-540
Objective: To analyze the influence of inflammation and benign prostatic en
largement on total and percent free serum prostatic specific antigen IPSA).
Patients and Methods: Total and free PSA serum levels were determined in 28
4 patients with no evidence of cancer in the sextant ultrasound-guided biop
sy. Double antibody immunoradiometric assay Tandem and Tandem free PSA were
used. Benign tissue without inflammation was found in 23.2% of the patient
s (group 1), while in 68.3%, it was associated with chronic prostatitis (gr
oup 2) and with acute prostatitis in 8.4% (group 3).
Results: Median serum PSA was 7.8 ng/ml in group 1, 6.7 ng/ml in group 2 an
d 6.4 ng/ml in group 3, p>0.05. Median percent free PSA was 14.1, 15.6 and
16.4%, respectively, p>0.05. Multiple linear regression analysis showed tha
t prostatic size was the only significant contributor to serum PSA concentr
ation. Moreover, total PSA and prostatic size contributed significantly to
the percent free serum PSA. Inflammation had no significant influence on to
tal or percent free serum PSA.
Conclusion: Inflammation has an important prevalence in cancer-free prostat
ic biopsy specimens. It seems to have no significant influence on total and
percent free serum PSA. However, prostatic size seems to be the major cont
ributor. Copyright (C) 2000 S. Karger AG. Basel.